HLS Therapeutics

HLS Therapeutics Inc. was founded in 2015 as a specialty pharmaceutical company focused on late-stage development, commercial-stage promotion, and the acquisition and commercialization of branded pharmaceutical products for the North American market. HLS concentrates on products within the central nervous system and cardiovascular therapeutic areas. The management team of HLS is composed of seasoned pharmaceutical executives with a proven track record of success in these therapeutic fields as well as in product management across all lifecycle stages.